Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Hemorrhage × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2 Sarcoma 1

Conditions

Sarcoma 153 Glioblastoma 65 Gliosarcoma 64 Brain Neoplasms 37 Osteosarcoma 36 Neoplasms 36 Astrocytoma 35 Recurrence 33 Melanoma 30 Gastrointestinal Stromal Tumors 30 Oligodendroglioma 29 Precursor Cell Lymphoblastic Leukemia-Lymphoma 28 Lymphoma 28 Dendritic Cell Sarcoma, Interdigitating 28 Breast Neoplasms 28 Glioma 27 Bone Neoplasms 27 Central Nervous System Neoplasms 26 Burkitt Lymphoma 26 Neoplasm Metastasis 25 Colorectal Neoplasms 23 Ovarian Neoplasms 22 Lymphoma, Large B-Cell, Diffuse 22 Sarcoma, Ewing 21 Neuroblastoma 21 Lymphoma, Non-Hodgkin 21 Stomach Neoplasms 19 Leukemia, Myeloid, Acute 19 Leukemia 19 Leukemia, Lymphocytic, Chronic, B-Cell 18

Interventions

Tranexamic Acid 1 Fibrin Tissue Adhesive 1 Diathermy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02153593 2016-09-20

TRANEXTUM

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Phase 3 Terminated

Bone Neoplasms, Hemorrhage

Data powered by HemOnc (CC BY 4.0) Colophon ⚡